E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/21/2005 in the Prospect News PIPE Daily.

New Issue: CytRx to raise $21.3 million in private placement of shares

By Sheri Kasprzak

Atlanta, Jan. 21 - CytRx Corp. has received agreements for a $21.3 million private placement of stock.

The company will sell 17,334,494 shares at $1.23 each to institutional investors.

The investors will also receive warrants for 8,667,247 shares at $2 each.

Rodman & Renshaw LLC was the placement agent in the deal.

Based in Los Angeles, CytRx is a biopharmaceutical research and development company.

Issuer:CytRx Corp.
Issue:Stock
Amount:$21.3 million
Shares:17,334,494
Price:$1.23
Warrants:For 8,667,247 shares
Warrant strike price:$2.00
Placement agent:Rodman & Renshaw LLC
Announcement date:Jan. 21
Stock price:$1.60 at close Jan. 20

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.